Conditions: Adult B Lymphoblastic Lymphoma; Childhood B Acute Lymphoblastic Leukemia; Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1; Childhood B Lymphoblastic Lymphoma; Down Syndrome; Stage I B Lymphoblastic Lymphoma; Stage II B Lymphoblastic Lymphoma; Untreated Adult Acute Lymphoblastic Leukemia; Untreated Childhood Acute Lymphoblastic Leukemia Interventions: Drug: Cyclophosphamide; Drug: Cytarabine; Drug: Dexamethasone; Drug: Doxorubicin Hydrochloride; Other: Laboratory Biomarker Analysis; Drug: Leucovorin Calcium; Drug: Mercaptopurine; Drug: Methotrexate; Drug: Pegaspargase; Other: Quality-of-Life Assessment; Other: Questionnaire Administration; Drug: Thioguanine; Drug: Vincristine Sulfate

Principal Investigator:
Shen, Violet

Research Coordinator:
Kathryn Duvall
(714) 509-8646

Visit for more information about this trial.

  • Clinical Trial Info
  • IRB Number: 100880
  • Sponsor: COG
  • Protocol Number: AALL0932
  • NCT Number: NCT01190930
  • Research Type: Leukemia/Lymphoma
  • Phase: III
  • Status: Active - Closed to Enrollment